The intact rat pancreas's GIP perfusion only stimulates glucagon secretion at low glucose levels (4.4 mM) and not at postprandial glucose concentrations (8.9 mM), suggesting that GIP receptor activity in the cell appears to be glucose dependent [18]
The impact of approved anti-obesity medications on osteoarthritis
Yes, IV therapy may support hydration, nutrient balance, energy, and recovery during your weight loss program
Beyond medication transfer into breast milk, it is important to consider the nutritional demands of lactation and if a GLP-1 is an appropriate medication to use during this time
The following features would enhance the value of an obesity therapeutic, but would likely be assessed in follow-up trials or even post-approval: Additional efficacy in obesity-related co-morbidities
Addressing biological factors such as hormones, metabolism, and appetite regulation gives patients a real chance at lasting results